英飞拓(002528) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was ¥366,856,192.77, a decrease of 52.32% compared to ¥769,410,393.61 in the same period last year[6]. - The net profit attributable to shareholders was -¥88,385,140.24, representing a decline of 32.33% from -¥66,790,903.49 year-on-year[6]. - Total revenue for the current period is CNY 366,856,192.77, a decrease of 52.4% compared to CNY 769,410,393.61 in the previous period[30]. - The net loss for the current period is CNY -88,592,482.74, compared to a net loss of CNY -67,543,555.28 in the previous period[33]. - The company reported a net loss attributable to shareholders of approximately 88.09 million, compared to a loss of 57.08 million in the previous period, representing an increase in losses[37]. - Basic and diluted earnings per share were both -0.0737, compared to -0.0557 in the previous period, indicating a worsening performance[37]. Cash Flow - The net cash flow from operating activities was ¥63,088,440.32, down 47.86% from ¥120,998,833.91 in the previous year[6]. - The net cash flow from operating activities was 63.09 million, down from 120.99 million in the previous period, reflecting a decrease of about 47.8%[41]. - The cash inflow from operating activities totaled approximately 848.89 million, while cash outflow was 785.80 million, resulting in a net cash flow of 63.09 million[41]. - The net cash flow from financing activities was 86.12 million, slightly up from 82.90 million in the previous period, showing a modest improvement[44]. - The company received approximately 20.23 million in cash related to financing activities, indicating ongoing financial operations[44]. Assets and Liabilities - Total assets at the end of the reporting period were ¥6,174,260,464.72, an increase of 1.50% from ¥6,082,898,785.75 at the end of the previous year[6]. - Total liabilities are CNY 3,942,017,850.33, up from CNY 3,762,391,020.77 in the previous period[29]. - The company's equity attributable to shareholders is CNY 2,240,044,431.50, down from CNY 2,328,133,938.87 in the previous period[29]. - Long-term borrowings increased to CNY 417,600,000.00 from CNY 317,800,000.00 in the previous period[29]. Investments and Expenses - The net cash flow from investing activities was -¥738,705,226.49, a significant increase in outflow compared to -¥8,764,922.11 in the previous year, mainly due to the purchase of structured deposits[12]. - The cash outflow for investing activities was approximately 740.11 million, significantly higher than the previous period's outflow of 9.54 million, reflecting increased investment activities[41]. - Research and development expenses decreased by 42.67% to ¥28,378,159.24, reflecting a reduction in the scope of consolidation[10]. - Research and development expenses amount to CNY 28,378,159.24, a decrease of 42.6% from CNY 49,497,279.25 in the previous period[33]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 56,032[14]. - The largest shareholder, Shenzhen Investment Holdings Co., Ltd., holds 26.35% of shares, totaling 315,831,160 shares[14]. - The company raised a total of 751,999,998.12 RMB from a private placement, with a net amount of 733,084,019.60 RMB after expenses[19]. - As of March 31, 2022, the company has utilized 796,033,646.31 RMB of the raised funds, exceeding the total raised amount due to interest income[19]. - The remaining balance of raised funds as of March 31, 2022, is 23,030,294.99 RMB[19]. Inventory and Receivables - The company reported a significant increase in accounts receivable, which rose by 303.35% to ¥5,517,997.64 due to an increase in commercial acceptance bills[10]. - The total amount of accounts receivable is 1,350,793,734.08 RMB, down from 1,467,482,265.71 RMB[23]. - The company's inventory stands at 549,538,914.07 RMB, slightly up from 534,107,241.63 RMB at the beginning of the year[23]. - The company reported a significant decrease in cash received from sales of goods and services, totaling approximately 681.82 million, compared to 1.28 billion in the previous period, a decline of about 46.5%[38].